GRNA Annual CFF
$200.85 M
+$157.32 M+361.40%
31 December 2022
Summary:
As of February 5, 2025, GRNA annual cash flow from financing activities is $200.85 million, with the most recent change of +$157.32 million (+361.40%) on December 31, 2022. During the last 3 years, it has risen by +$187.53 million (+1408.34%).GRNA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRNA Quarterly CFF
-$2.99 M
-$925.00 K-44.82%
31 March 2023
Summary:
As of February 5, 2025, GRNA quarterly cash flow from financing activities is -$2.99 million, with the most recent change of -$925.00 thousand (-44.82%) on March 31, 2023. Over the past year, it has dropped by -$105.49 million (-102.92%).GRNA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRNA TTM CFF
$95.36 M
-$105.49 M-52.52%
31 March 2023
Summary:
As of February 5, 2025, GRNA TTM cash flow from financing activities is $95.36 million, with the most recent change of -$105.49 million (-52.52%) on March 31, 2023. Over the past year, it has dropped by -$48.03 million (-33.49%).GRNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRNA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +361.4% | -102.9% | -33.5% |
| 3 y3 years | +1408.3% | - | - |
| 5 y5 years | +1408.3% | - | - |
GRNA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -102.9% | -58.2% |
GreenLight Biosciences Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$2.99 M(+44.8%) | $95.36 M(-52.5%) |
| Dec 2022 | $200.85 M(+361.4%) | -$2.06 M(-102.0%) | $200.85 M(-11.9%) |
| Sept 2022 | - | $104.27 M(-2805.6%) | $228.07 M(+68.0%) |
| June 2022 | - | -$3.85 M(-103.8%) | $135.73 M(-5.3%) |
| Mar 2022 | - | $102.50 M(+307.5%) | $143.39 M(+229.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $43.53 M(-65.4%) | $25.16 M(+110.8%) | $43.53 M(+136.9%) |
| Sept 2021 | - | $11.93 M(+213.1%) | $18.38 M(+185.1%) |
| June 2021 | - | $3.81 M(+44.7%) | $6.45 M(+144.7%) |
| Mar 2021 | - | $2.63 M | $2.63 M |
| Dec 2020 | $125.85 M(+845.1%) | - | - |
| Dec 2019 | $13.32 M | - | - |
FAQ
- What is GreenLight Biosciences Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for GreenLight Biosciences Holdings?
- What is GreenLight Biosciences Holdings annual CFF year-on-year change?
- What is GreenLight Biosciences Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for GreenLight Biosciences Holdings?
- What is GreenLight Biosciences Holdings quarterly CFF year-on-year change?
- What is GreenLight Biosciences Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for GreenLight Biosciences Holdings?
- What is GreenLight Biosciences Holdings TTM CFF year-on-year change?
What is GreenLight Biosciences Holdings annual cash flow from financing activities?
The current annual CFF of GRNA is $200.85 M
What is the all time high annual CFF for GreenLight Biosciences Holdings?
GreenLight Biosciences Holdings all-time high annual cash flow from financing activities is $200.85 M
What is GreenLight Biosciences Holdings annual CFF year-on-year change?
Over the past year, GRNA annual cash flow from financing activities has changed by +$157.32 M (+361.40%)
What is GreenLight Biosciences Holdings quarterly cash flow from financing activities?
The current quarterly CFF of GRNA is -$2.99 M
What is the all time high quarterly CFF for GreenLight Biosciences Holdings?
GreenLight Biosciences Holdings all-time high quarterly cash flow from financing activities is $104.27 M
What is GreenLight Biosciences Holdings quarterly CFF year-on-year change?
Over the past year, GRNA quarterly cash flow from financing activities has changed by -$105.49 M (-102.92%)
What is GreenLight Biosciences Holdings TTM cash flow from financing activities?
The current TTM CFF of GRNA is $95.36 M
What is the all time high TTM CFF for GreenLight Biosciences Holdings?
GreenLight Biosciences Holdings all-time high TTM cash flow from financing activities is $228.07 M
What is GreenLight Biosciences Holdings TTM CFF year-on-year change?
Over the past year, GRNA TTM cash flow from financing activities has changed by -$48.03 M (-33.49%)